Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1980418Generated: October 30, 2026

Dicyclohexylcarbodiimide → HCID 53845922, compound

https://huagongshe.com/reaction/1980418

Reaction equation

Participants

RoleNameHCIDCharge
ReactantDicyclohexylcarbodiimideHCID 10868—
Reactant(Z)-2-(2-Tritylaminothiazol-4-yl)-2-methoxyiminoacetic acidHCID 2724510—
ReactantHCID 20402459HCID 20402459—
SolventDichloromethaneHCID 6344—
ProductHCID 53845922HCID 538459227.5%

Reaction Steps

The syn isomer of 2-methoxyimino-2-(2-tritylaminothiazol-4-yl)-acetic acid (12.4 g) and 4-N,N-dimethylaminopyridine (0.05 g) are added to a solution of 7-amino-2-benzhydryloxycarbonyl-8-oxo-3-[2-(pyridin-4-yl)-thiazol-5-yl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene 5-oxide (15 g) in dry methylene chloride (100 cc), and a solution of N,N'-dicyclohexylcarbodiimide (6.93 g) in methylene chloride (120 cc) is then added (in the course of 30 minutes) after cooling to +5° C. The reaction mixture is then stirred for 1 hour at +5° C. and then for 4 hours at 25° C., after which it is partially concentrated, diluted again with ethyl acetate (500 cc) and filtered. The filtrate is poured into a mixture of distilled water (1 liter), ethyl acetate (1 liter) and acetic acid (10 cc). The organic phase is washed with a saturated solution of sodium bicarbonate (200 cc), distilled water (3×200 cc) and then a saturated solution of sodium chloride (200 cc), dried over sodium sulphate and then concentrated to dryness under reduced pressure (30 mm Hg; 4 kPa) at 40° C. to give the crude expected product (26.8 g) in the form of a hard brown foam, which can be purified in the following manner: the crude product (5 g) is redissolved in ethanol (120 cc) under reflux, decolorising charcoal (0.5 g) and silica (0.5 g) are added, the mixture is stirred and filtered and the filtrate is cooled in a bath of iced water. The precipitate is filtered off and washed with ethanol (2×10 cc) and then ether (2×20 cc) to give 2-benzhydryloxycarbonyl-7-[2-methoxyimino-2-(2-tritylaminothiazol-4-yl)acetamido]-8-oxo-3-[2-(pyridin-4-yl)-thiazol-5-yl]-5-thia1-azabicyclo[4.2.0]oct-2-ene 5-oxide (2 g) in the form of an ochre powder.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS04508717
Source datasetuspto-grants-1985_04
ORD IDord-c88caeba165e4ea18aeb7ee075794a68
Source noteuspto-grants-1985_04